Fenofibrate, a Peroxisome Proliferator-Activated Receptor α Agonist, Improves Hepatic Microcirculatory Patency and Oxygen Availability in a High-Fat-Diet-Induced Fatty Liver in Mice-Reference-Cited by-同舟云学术

Fenofibrate, a Peroxisome Proliferator-Activated Receptor α Agonist, Improves Hepatic Microcirculatory Patency and Oxygen Availability in a High-Fat-Diet-Induced Fatty Liver in Mice

Published:2009-10-24 Issue: Volume: Page:77-82
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

Kondo Kazunari,Sugioka Tadao,Tsukada Kosuke,Aizawa Michiyoshi,Takizawa Masayuki,Shimizu Kenji,Morimoto Masaya,Suematsu Makoto,Goda Nobuhito

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4419-1241-1_10.pdf

Reference8 articles.

1. Irukayama-Tomobe Y, Miyauchi T, Sakai S et al. (2004) Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway. Circulation 109(7):904–910.

2. Lee SS, Pineau T, Drago J et al. (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15:3012–3022.

3. Lefebvre P, Chinetti G, Fruchart JC et al. (2006) Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 116(3):571–580.

4. Murakami H, Murakami R, Kambe F et al. (2006) Fenofibrate activates AMPK and increases eNOS phosphorylation in HUVEC. Biochem Biophys Res Commun 341(4):973–978.

5. Postic C, Girard J (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118(3):829–838.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma;Drug Resistance Updates;2024-05

2. Role of liver in gallstone formation;Gallstone Formation, Diagnosis, Treatment and Prevention;2024

3. Gemfibrozil Improves Microcirculatory Oxygenation of Colon and Liver without Affecting Mitochondrial Function in a Model of Abdominal Sepsis in Rats;International Journal of Molecular Sciences;2023-12-23

4. The role of hypoxia-inducible factor 1α in hepatic lipid metabolism;Journal of Molecular Medicine;2023-03-28

5. Down-regulation of hepatic CLOCK by PPARα is involved in inhibition of NAFLD;Journal of Molecular Medicine;2022-12-17